Exhaled nitric oxide measurement is not useful for predicting the response to inhaled corticosteroids in subjects with chronic cough

Chest

Volumn 136, Issue 3, 2009, Pages 816-822

  Prieto, Luis ^a,b   Ferrer, Anna ^a   Ponce, Silvia ^b   Palop, Julio ^b   Marín, Julio ^c  

^a Asociacion Valenciana de Investigaciones Clinicas   (Spain)

^b HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; CORTICOSTEROID; DIARYL KETONE; FLUTICASONE PROPIONATE; METHACHOLINE; NITRIC OXIDE;

ADULT; AGED; ARTICLE; BRONCHUS HYPERREACTIVITY; CHRONIC DISEASE; CLINICAL ARTICLE; COUGHING; DRUG RESPONSE; FEMALE; HUMAN; MALE; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPIROMETRY; SYMPTOM; TREATMENT RESPONSE;

EID: 70049112525     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.08-2942     Document Type: Article

References (34)

1. Boulet LP, Milot J, Boutet M, et al. Airway inflammation in nonasthmatic subjects with chronic cough. Am J Respir Crit Care Med 1994; 149:482-489 (Pubitemid 24069000)
2. Jatakanon A, Lalloo UG, Lim S, et al. Increased neutrophils and cytokines, TNF-α and IL-8, in induced sputum of non-asthmatic patients with chronic dry cough. Thorax 1999; 54:234-237 (Pubitemid 29110503)
3. Lee SY, Cho JY, Shim JJ, et al. Airway inflammation as an assessment of chronic nonproductive cough. Chest 2001; 120:1114-1120
4. Gibson PG, Zlatic K, Scott J, et al. Chronic cough resembles asthma with IL-5 and granulocyte-macrophage colony-stimulating factor gene expression in bronchoalveolar cells. J Allergy Clin Immunol 1998; 101:320-326 (Pubitemid 28146349)
5. McGarvey LPA, Forsythe P, Heaney LG, et al. Bronchoalveolar lavage findings in patients with chronic nonproductive cough. Eur Respir J 1999; 13:59-66 (Pubitemid 29079220)
6. Niimi A, Torrego A, Nicholson AG, et al. Nature of airway inflammation and remodeling in chronic cough. J Allergy Clin Immunol 2005; 116:565-570 (Pubitemid 41267129)
7. Irwin RS, Ownbey R, Cagle PT, et al. Interpreting the histopathology of chronic cough: a prospective, controlled, comparative study. Chest 2006; 130:362-370 (Pubitemid 44267001)
8. Brightling CE, Ward R, Goh KL, et al. Eosinophilic bronchitis is an important cause of chronic cough. Am J Respir Crit Care Med 1999; 160:406-410 (Pubitemid 29380649)
9. Brightling CE, Bradding P, Symon FA, et al. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002; 346:1699-1705 (Pubitemid 34547483)
10. Pratter MR. Upper airway cough syndrome (previously referred to as postnasal drip syndrome): ACCP evidence-based clinical practice guidelines. Chest 2006; 129(suppl):63S-71S
11. Birring SS, Brightling CE, Symon FA, et al. Idiopathic chronic cough: associations with organ specific autoimmune disease and bronchoalveolar lymphocytosis. Thorax 2003; 58:1066-1070
12. Morice AH, McGarvey L, Pavord I, et al. Recommendations for the management of cough in adults. Thorax 2006; 61(suppl):1S-24S
13. Irwin RS, French CT, Smyrnios NA, et al. Interpretation of positive results of a methacholine inhalation challenge and 1 week of inhaled bronchodilator use in diagnosing and treating cough-variant asthma. Arch Intern Med 1997; 157:1981-1987
14. Galvez RA, McLaughlin FJ, Levison H. The role of the methacholine challenge in children with chronic cough. J Allergy Clin Immunol 1987; 79:331-335 (Pubitemid 17023086)
15. 20 methacholine. Am J Respir Crit Care Med 2001; 163:1546-1550
16. 20 of methacholine. Am J Respir Crit Care Med 2001; 164:1127-1132
17. Pizzichini MMM, Pizzichini E, Parameswaran K, et al. Non-asthmatic chronic cough: no effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. Can Respir J 1999; 6:323-330
18. Jatakanon A, Lim S, Kharitonov SA, et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998; 53:91-95 (Pubitemid 28212132)
19. Berlyne GS, Parameswaran K, Kamada D, et al. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 2000; 106:638-644 (Pubitemid 30799717)
20. Chaudhuri R, McMahon AD, Thomson LJ, et al. Effect of inhaled corticosteroids on symptoms severity and sputum mediator levels in chronic persistent cough. J Allergy Clin Immunol 2004; 113:1063-1070 (Pubitemid 38857987)
21. Sato S, Saito J, Sato Y, et al. Clinical usefulness of fractional exhaled nitric oxide for diagnosing prolonged cough. Respir Med 2008; 102:1452-1459
22. Chatkin JM, Ansarin K, Silkoff PE, et al. Exhaled nitric oxide as a noninvasive assessment of chronic cough. Am J Respir Crit Care Med 1999; 159:1810-1813 (Pubitemid 29275047)
23. Oh MJ, Lee JY, Lee BJ, et al. Exhaled nitric oxide measurement is useful for the exclusion of nonasthmatic eosinophilic bronchitis in patients with chronic cough. Chest 2008; 134: 990-995
24. Hsu JY, Stone RA, Logan-Sinclair RB, et al. Coughing frequency in patients with persistent cough: assessment using a 24 hour ambulatory recorder. Eur Respir J 1994; 7:1246-1253
25. American Thoracic Society. Standardization of spirometry: 1987 update. Am Rev Respir Dis 1987; 136:1285-1298
26. Chai H, Ferr RS, Froehlich LA, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56:323-327
27. American Thoracic Society. Guidelines for methacholine and exercise challenge testing: 1999. Am J Respir Crit Care Med 2000; 161:309-329
28. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 2005; 171:912-930
29. Prieto L, Gutierrez V, Uixera S, et al. Concentrations of exhaled nitric oxide in asthmatics and subjects with allergic rhinitis sensitized to the same pollen allergen. Clin Exp Allergy 2002; 32:1728-1733 (Pubitemid 35463857)
30. Prieto L, Bruno L, Gutierrez V, et al. Airway responsiveness to adenosine 5′-monophosphate and exhaled nitric oxide measurements: predictive value as markers for reducing the dose of inhaled corticosteroids in asthmatic subjects. Chest 2003; 124:1325-1333 (Pubitemid 37290042)
31. Prieto L, Gutierrez V, Perez-Frances C, et al. Effect of fluticasone propionate-salmeterol therapy on seasonal changes in airway responsiveness and exhaled nitric oxide levels in patients with pollen-induced asthma. Ann Allergy Asthma Immunol 2005; 95:452-461 (Pubitemid 41688507)
32. Burrows B, Sears MR, Flannery EM, et al. Relations of bronchial responsiveness to allergy skin test reactivity, lung function, respiratory symptoms, and diagnoses in thirteen-year-old New Zealand children. J Allergy Clin Immunol 1995; 95:548-556
33. Hahn PY, Morgenthaler TI, Lim KG. Use of exhaled nitric oxide in predicting response to inhaled corticosteroids for chronic cough. Mayo Clin Proc 2007; 82:1350-1355
34. Freestone C, Eccles R. Assessment of the antitussive efficacy of codeine in cough associated with common cold. J Pharm Pharmacol 1997; 49:1045-1049 (Pubitemid 27478402)